Bibliografía
1. Parkin DM, Bray F, F Ferlay J, Pisani P. Global Cancer Statistics, 2002. C A Cancer J Clin 2005; 74-108.
2. Sankaranarayanan R, Fernández Garrote L, Lence Anta J, Pisan P, Rodríguez Salva A. Visual inspection in oral
cancer screening in Cuba: a case control study. Oral Oncol 2003; 38 (2) 131-6.
3. Sand L, Jalouli J, Larsson P A, Hirsch J M. Human Papillomavirus in oral lesions. Anticancer Res 2000; 1183-8.
4. Santana. Garay. J. C, Prevención y Diagnóstico del Cáncer Bucal.1ra ed. La Habana: Ed Ciencias Medicas; 2002.p. 47-55.
5. Melrouse R J. Premalignant Oral Mucosal Disease. J Calif Dent Ass 2002, 45-52.
6. Bokor-Bratic M, Vuckovic N, Mirkovic S. Correlation between clinical and histopathologic diagnoses of potentially
malignant oral lesions. Arch Oncol 2004, 12(3):145-8.
7. Herrero R, Castellsagué X, Pawlita M, Kee F, Balaram P, et. al. Humans Papillomavirus and oral cancer. The
International Agency for Research on Cancer Multicenter Study. J Natl Cancer Inst 2003; 95: 1772-83.
8. Smith E M, Ritchie J M, Summersgill K F, Hoffman H T, Dong Hong Wang, Haugen T H, Turek L P. Human
Papillomavirus in Oral exfoliated Cells and Risk of Head and Neck Cancer. J Natl Cancer Inst 2004; 96 (6):449-55.
9. Oral Cancer Background Papers. Chapter II: Histopathology, Biology and Markers. Working Draft. 2002.
10. Gillison M L, Koch W M, Capone R B, Spafford M, Westra W H, Wu L, et al. Evidence for a causal association between human Papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000; 92: 709-20.
11. Ostwald C, Rutsatz K, Schweder J, Schmidt W, Gundiach K, Barten M. Human Papillomavirus 6/11, 16 and 18 in oral carcinoma and benign oral lesions. Med Microbiol Immunol ( Berl) 2003; 192 (3): 145-8.
|